CTCs analysis: an update on technological progress

There is a growing need for a more accurate, real-time assessment of tumor status and the probability of metastasis, relapse, or response to treatment. Conventional means of assessment include imaging and tissue biopsies which can be highly invasive, may not provide complete information of the disease's heterogeneity, and not ideal for repeat analysis. Therefore, a less invasive means of acquiring similar information at greater time points is necessary. Liquid biopsies are samples of a patients ’ peripheral blood and hold potential of addressing these criteria.

Source: Translational Research - July 10, 2019 Category: Research Authors: Izhar S. Batth, Abhisek Mitra, Sierra Rood, Scott Kopetz, David Menter, Shulin Li Tags: Review Article Source Type: research